Search results for "Guide"

showing 10 items of 1478 documents

On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion

2021

Radiochemical conversion is an important term to be included in the "Consensus nomenclature rules for radiopharmaceutical chemistry". Radiochemical conversion should be used to define reaction efficiency by measuring the transformation of components in a crude reaction mixture at a given time, whereas radiochemical yield is better suited to define the efficiency of an entire reaction process including, for example, separation, isolation, filtration, and formulation. (C) 2020 Elsevier Inc. All rights reserved.

Cancer ResearchRadiochemistryNomenclatureRadiochemical conversionChemistryRadiochemistry610 Medicine & health10181 Clinic for Nuclear MedicineTerminology030218 nuclear medicine & medical imagingNuclear chemistryRadiochemical yield03 medical and health sciences0302 clinical medicineddc:5701313 Molecular Medicine030220 oncology & carcinogenesisYield (chemistry)2741 Radiology Nuclear Medicine and ImagingMolecular Medicine1306 Cancer ResearchRadiology Nuclear Medicine and imagingRadiopharmaceutical sciencesConsensus guidelinesNuclear Medicine and Biology
researchProduct

Guidelines for Long-Term Follow-Up after Childhood Cancer: Practical Implications for the Daily Work

2019

<b><i>Background:</i></b> Many childhood cancer survivors develop treatment-associated late effects emerging years or even decades after the end of treatment. Evidence-based guidelines recommend risk-adapted screening, facilitating early diagnosis and management of these sequelae. Long-term follow-up (LTFU) in specialized late effects clinics is devised to implement screening recommendations in the care of childhood cancer survivors. <b><i>Objectives:</i></b> To create a practical LTFU tool for the daily practice. <b><i>Methods:</i></b> Current guidelines and screening recommendations concerning LTFU in adult survivors …

Cancer Researchmedicine.medical_specialtyLong term follow upChildhood cancerMultidisciplinary team03 medical and health sciences0302 clinical medicineRisk groupsCancer SurvivorsPatient Education as TopicNeoplasmsDaily practicemedicineHumans030212 general & internal medicineChildIntensive care medicinePractical implicationsbusiness.industryHematologyContinuity of Patient CareOncologyWork (electrical)030220 oncology & carcinogenesisRisk stratificationDisease ProgressionGuideline AdherencebusinessDelivery of Health CareFollow-Up StudiesOncology Research and Treatment
researchProduct

Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria

2007

Since the initial description of splenic marginal zone lymphoma (SMZL) in 1992, an increasing number of publications have dealt with multiple aspects of SMZL diagnosis, molecular pathogenesis and treatment. This process has identified multiple inconsistencies in the diagnostic criteria and lack of clear guidelines for the staging and treatment. The authors of this review have held several meetings and exchanged series of cases with the objective of agreeing on the main diagnostic, staging and therapeutic guidelines for patients with this condition. Specific working groups were created for diagnostic criteria, immunophenotype, staging and treatment. As results of this work, guidelines are pr…

Cancer Researchmedicine.medical_specialtyMEDLINElymphomaComorbiditySettore MED/08 - Anatomia PatologicaAntiviral AgentsImmunophenotypingDiagnosis DifferentialAntibodies Monoclonal Murine-DerivedBone MarrowAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumormedicineHumansCombined Modality TherapySplenic marginal zone lymphomaIntensive care medicineSplenic marginal zone lymphomaNeoplasm StagingChromosome Aberrationsbusiness.industrySplenic NeoplasmsAntibodies MonoclonalDisease ManagementLymphoma B-Cell Marginal ZoneHematologyHepatitis C ChronicPrognosismedicine.diseaseCombined Modality TherapyComorbidityLymphomaSurgeryClinical trialOncologyPractice Guidelines as TopicSplenectomyRituximabDifferential diagnosisRituximabbusinessguidelineSpleenmedicine.drugLeukemia
researchProduct

European code against cancer 4th edition: 12 ways to reduce your cancer risk

2015

AbstractThis overview describes the principles of the 4th edition of the European Code against Cancer and provides an introduction to the 12 recommendations to reduce cancer risk. Among the 504.6 million inhabitants of the member states of the European Union (EU28), there are annually 2.64 million new cancer cases and 1.28 million deaths from cancer. It is estimated that this cancer burden could be reduced by up to one half if scientific knowledge on causes of cancer could be translated into successful prevention. The Code is a preventive tool aimed to reduce the cancer burden by informing people how to avoid or reduce carcinogenic exposures, adopt behaviours to reduce the cancer risk, or t…

Cancer Researchmedicine.medical_specialtyQuality Assurance Health CareEpidemiologyUterine Cervical NeoplasmsCancer preventionCauses of cancerCancer screeningBreast cancerRisk FactorsEnvironmental healthCancer screeningmedicinemedia_common.cataloged_instanceHumansEuropean UnionEuropean unionPreventive healthcaremedia_commonCervical cancerCancer risk factorsCancer preventionbusiness.industryCancermedicine.diseaseEuropeOncology1117 Public Health And Health ServicesWorking Groups of Scientific ExpertsPractice Guidelines as TopicFemalebusiness1112 Oncology And Carcinogenesis
researchProduct

Is guideline-adherent adjuvant treatment an equivalent option for elderly patients who cannot participate in adjuvant clinical breast cancer trials? …

2014

1063 Background: It is well accepted that innovation in oncology is transported through randomized clinical trials (CT). However, elderly patients (>65) are usually excluded from CT. Therefore this...

Cancer Researchmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentGuidelinemedicine.diseaseSurgerylaw.inventionBreast cancerOncologyRandomized controlled triallawInternal medicinemedicinebusinessAdjuvantCohort studyJournal of Clinical Oncology
researchProduct

Participation in adjuvant clinical breast cancer trials: Is there a difference in survival compared to guideline adherent adjuvant treatment? A retro…

2012

1082 Background: Clinical trials (CT) usually compare a standard treatment regime versus innovative new substances or regimens. However participation in CT is available for only few patients and exclusion criteria is usually very strict. Therefore this study tries to answer the following questions: (1) Does participation in adjuvant CT improve survival in breast cancer (BC)? (2) Is there a difference in survival compared to guideline adherence and what is the role of the other treatments surrounding adjuvant breast cancer treatment? Methods: This German multi-center [17 participating hospitals all are certified as breast cancer centers] retrospective cohort study called BRENDA (BRENDA = qu…

Cancer Researchmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentStandard treatmentGuidelinemedicine.diseaseClinical trialBreast cancerOncologyInternal medicinemedicinePhysical therapybusinessAdjuvantCohort studyJournal of Clinical Oncology
researchProduct

Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV)

2020

El diagnóstico y tratamiento del melanoma en atención especializada es un campo en el que se han producido numerosos cambios. El objetivo de esta guía es ofrecer a los dermatólogos españoles una referencia para resolver las dudas clínicas más frecuentes basándose en la evidencia actual. Para la realización de esta guía se escogió a miembros del Grupo Español de Dermato-Oncología y Cirugía con experiencia en el tratamiento de estos tumores y con interés en participar en la elaboración de la guía. Se hizo una adaptación de las guías de práctica clínica existentes mediante el método ADAPTE: inicialmente se resumió el proceso de atención y se elaboraron las preguntas clínicas relevantes. Se sel…

Care processmedicine.medical_specialtyPractice guidelineHistologyVenereologySkin NeoplasmsBiopsyTerapéuticaAntineoplastic AgentsDermatologyTherapeutics030204 cardiovascular system & hematologyPathology and Forensic MedicineHutchinson's Melanotic Freckle03 medical and health sciences0302 clinical medicineDiagnòsticDiagnosismedicineRelevance (law)HumansAgree ii030212 general & internal medicineNeoplasm MetastasisMelanomaNeoplasm StagingEvidence-Based Medicinebusiness.industrySentinel Lymph Node BiopsyDiagnósticoDisease ManagementGuidelineDiagnosis Diagnóstico Guía de práctica clínica Melanoma Practice guideline Terapéutica TherapeuticsTerapèuticaPatient preferenceDermatologyCombined Modality TherapyClinical PracticeGuía de práctica clínicaMolecular Diagnostic Techniquesbusiness
researchProduct

Biostable Scaffolds of Polyacrylate Polymers Implanted in the Articular Cartilage Induce Hyaline-Like Cartilage Regeneration in Rabbits

2017

[EN] Purpose: To study the influence of scaffold properties on the organization of ¿in vivo¿ cartilage regeneration. Our hypothesis is that stress transmission to the cells seeded inside the scaffold pores or surrounding it, which is highly dependent on the scaffold properties, determine differentiation of both mesenchymal cells and dedifferentiated autologous chondrocytes. Methods: Four series of porous scaffolds made of different polyacrylate polymers, previously seeded with cultured rabbit chondrocytes or without cells preseeded, were implanted in cartilage defects in rabbits. Subchondral bone was always injured during the surgery in order to allow blood to reach the implantation site an…

Cartilage ArticularHyalinScaffold0206 medical engineeringBiomedical EngineeringMedicine (miscellaneous)Biocompatible MaterialsBioengineering02 engineering and technologyBiomaterialsBiopolymersChondrocytesTissue engineeringIn vivomedicineAnimalsRegenerationTissue engineeringOriginal Research ArticleHyalineScaffoldschemistry.chemical_classificationTissue ScaffoldsGuided Tissue RegenerationRegeneration (biology)CartilageMesenchymal stem cellCell DifferentiationMesenchymal Stem CellsGeneral MedicinePolymerAnatomy021001 nanoscience & nanotechnology020601 biomedical engineeringAnimal modelsDisease Models AnimalCartilagemedicine.anatomical_structureAcrylateschemistryFISICA APLICADAMAQUINAS Y MOTORES TERMICOSRabbits0210 nano-technologyBiomedical engineeringThe International Journal of Artificial Organs
researchProduct

Dynamic processes involved in the pre-vascularization of silk fibroin constructs for bone regeneration using outgrowth endothelial cells

2009

For successful bone regeneration tissue engineered bone constructs combining both aspects, namely a high osteogenic potential and a rapid connection to the vascular network are needed. In this study we assessed the formation of pre-vascular structures by human outgrowth endothelial cells (OEC) from progenitors in the peripheral blood and the osteogenic differentiation of primary human osteoblasts (pOB) on micrometric silk fibroin scaffolds. The rational was to gain more insight into the dynamic processes involved in the differentiation and functionality of both cell types depending on culture time in vitro. Vascular tube formation by OEC was assessed quantitatively at one and 4 weeks of cul…

Cell typeBone RegenerationAngiogenesisBiophysicsNeovascularization PhysiologicFibroinBioengineeringMatrix (biology)BiologyBiomaterialsTissue engineeringOsteogenesisHumansProgenitor cellBone regenerationCells CulturedTube formationTissue EngineeringTissue ScaffoldsGuided Tissue RegenerationEndothelial CellsCoculture TechniquesCell biologyMechanics of MaterialsCeramics and CompositesFibroinsBiomarkersBiomedical engineeringBiomaterials
researchProduct

Vantaggi degli ultrasuoni nel posizionamento di un agocannula nella vena giugulare interna (nuove note di tecnica)

2004

The authors analized the result of 175 central venous ca he- terization CVC. of internal jugular vein performed with the ultrasound guide (US) from January 1998 to October 2002. The average performing time was 45 minutes. 98.2% of success and 4% of complications (one pagal hypotension, one artery puncture, four catheter dislocation, one haeiuatoinai). The US guide CVC is a safe procedure with short performing time, low rate of failures and complications and high rate of success: it is helpful in all patients with vascular anatomical variations, with not visualized or Land marks and with coagulation disorders.

Central Venous catheterization CVC ultrasound guide
researchProduct